58
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Impact of adherence to biological agents on health care resource utilization for patients over the age of 65 years with rheumatoid arthritis

, &
Pages 1133-1142 | Published online: 06 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Peter Takacs, Urja Lathia, Janey Shin & Francois Nantel. (2019) Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis. Patient Preference and Adherence 13, pages 157-163.
Read now

Articles from other publishers (12)

Claire E.H. Barber, Diane Lacaille, Ruth Croxford, Cheryl Barnabe, Deborah A. Marshall, Michal Abrahamowicz, Hui Xie, J. Antonio Aviña-Zubieta, John M. Esdaile, Glen S. Hazlewood, Peter Faris, Steven Katz, Paul MacMullan, Dianne Mosher & Jessica Widdifield. (2023) Investigating Associations Between Access to Rheumatology Care, Treatment, Continuous Care, and Healthcare Utilization and Costs Among Older Individuals With Rheumatoid Arthritis. The Journal of Rheumatology 50:5, pages 617-624.
Crossref
Zon-Min Lee, Yao-Hsu Yang, Ho-Chang Kuo, Ya-Han Shen, Hong-Ren Yu & Yu-Jih Su. (2022) Comparison of glucocorticoids and painkiller prescribed days between rheumatoid arthritis patients receiving early and late treatment with a biological agent via a population-based cohort study. Medicine 101:47, pages e31986.
Crossref
Francois Nantel, Juejing Ling, Meagan Rachich, Odalis Asin-Milan, Brad Millson, Shane Golden, Huijuan Yang, Purva Barot & Allen J. Lehman. (2022) Usage and Adherence of Seven Advanced Therapies with Differing Mechanisms of Action for Inflammatory Arthritis in Canada. Rheumatology and Therapy 9:5, pages 1399-1420.
Crossref
Luisa Martos-Cabrera, Alberto Calvo-Garcia, Beatriz Butron-Bris, Ana Reymundo, C. Santamaria, Enrique Ovejero-Merino, Esteban Dauden-Tello, Esther Ramirez- Herraiz & Mar Llamas-Velasco. (2021) Intense Impact of Health Alert Due to COVID-19 on Adherence of Moderate to Severe Psoriasis Patients to Hospital Therapy. Journal of Skin and Stem Cell 8:2.
Crossref
A Mark FendrickDiana BrixnerDavid T RubinPhilip MeaseHarry LiuMatthew DavisManish Mittal. (2021) Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit. Journal of Managed Care & Specialty Pharmacy 27:8, pages 1086-1095.
Crossref
Christina A. Spivey, Kevin L. Winthrop, Jenny Griffith, Cameron M. Kaplan, Yanru Qiao, Arnold E. Postlethwaite & Junling Wang. (2019) Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis. Rheumatology and Therapy 7:1, pages 133-147.
Crossref
Majed Khraishi, Brad Millson, John Woolcott, Heather Jones, Lisa Marshall & Nicolino Ruperto. (2019) Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis. Pediatric Rheumatology 17:1.
Crossref
Yoon-Jeong OhBumhee ParkKi Won Moon. (2019) Effect of Drug Adherence on Treatment Outcome in Rheumatoid Arthritis. Journal of Rheumatic Diseases 26:4, pages 264.
Crossref
Valentin Ritschl, Angelika Lackner, Carina Boström, Erika Mosor, Michaela Lehner, Maisa Omara, Romualdo Ramos, Paul Studenic, Josef Sebastian Smolen & Tanja Alexandra Stamm. (2018) I do not want to suppress the natural process of inflammation: new insights on factors associated with non-adherence in rheumatoid arthritis. Arthritis Research & Therapy 20:1.
Crossref
Brian Bressler, Martin Williamson, Bernie Sattin, Fernando Camacho & A Hillary Steinhart. (2018) Real World Effectiveness of Golimumab Therapy in Ulcerative Colitis Regardless of Prior TNF Exposure. Journal of the Canadian Association of Gastroenterology 1:3, pages 129-134.
Crossref
Kang Zheng, Zexu Chen, Wen Sun, Bin Liu, Danping Fan, Qingqing Guo, Hui Luo, Jiawen Shen, Li Li, Xiaojuan He, Shuang Kou, Xiaoya Li, Guoming Pang, Hongchuan Zhao & Cheng Lu. (2018) Hei-Gu-Teng Zhuifenghuoluo Granule Modulates IL-12 Signal Pathway to Inhibit the Inflammatory Response in Rheumatoid Arthritis. Journal of Immunology Research 2018, pages 1-10.
Crossref
John K. Marshall, Louis Bessette, Carter Thorne, Neil H. Shear, Gerald Lebovic, Sebastien K. Gerega, Brad Millson, Driss Oraichi, Tania Gaetano, Sandra Gazel, Martin G. Latour & Marie-Claude Laliberté. (2018) Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study. Clinical Therapeutics 40:3, pages 415-429.e6.
Crossref